These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 22504918

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Boceprevir and telaprevir in the management of hepatitis C virus-infected patients.
    Butt AA, Kanwal F.
    Clin Infect Dis; 2012 Jan 01; 54(1):96-104. PubMed ID: 22156853
    [Abstract] [Full Text] [Related]

  • 5. The first wave: HCV NS3 protease inhibitors telaprevir and boceprevir.
    Marks KM, Jacobson IM.
    Antivir Ther; 2012 Jan 01; 17(6 Pt B):1119-31. PubMed ID: 23188750
    [Abstract] [Full Text] [Related]

  • 6. Telaprevir: a hepatitis C NS3/4A protease inhibitor.
    Matthews SJ, Lancaster JW.
    Clin Ther; 2012 Sep 01; 34(9):1857-82. PubMed ID: 22951253
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Hepatitis C virus: 25 years-old, the end?].
    Pol S.
    Med Sci (Paris); 2013 Nov 01; 29(11):998-1003. PubMed ID: 24280503
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Future perspectives: towards interferon-free regimens for HCV.
    Gane E.
    Antivir Ther; 2012 Nov 01; 17(6 Pt B):1201-10. PubMed ID: 23186654
    [Abstract] [Full Text] [Related]

  • 13. A practical guide for the use of boceprevir and telaprevir for the treatment of hepatitis C.
    Jacobson IM, Pawlotsky JM, Afdhal NH, Dusheiko GM, Forns X, Jensen DM, Poordad F, Schulz J.
    J Viral Hepat; 2012 May 01; 19 Suppl 2():1-26. PubMed ID: 22404758
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Direct-acting antiviral (DAA) actions in treatment-naïve patients.
    Hézode C.
    Clin Res Hepatol Gastroenterol; 2011 Dec 01; 35 Suppl 2():S52-8. PubMed ID: 22248695
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.